Back to Search Start Over

P-272: Efficacy and safety of ixazomib plus lenalidomide and dexamethasone following injectable proteasome inhibitor-based therapy in patients with relapsed/refractory multiple myeloma

Authors :
Makoto Sasaki
Kenshi Suzuki
Yu Abe
Shigeki Ito
Kaichi Nishiwaki
Hiroshi Handa
Takaaki Chou
Junpei Soeda
Ikuo Mori
Tomohiro Shinozaki
Naoki Takezako
Source :
Clinical Lymphoma Myeloma and Leukemia. 22:S187-S188
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Cancer Research
Oncology
Hematology

Details

ISSN :
21522650
Volume :
22
Database :
OpenAIRE
Journal :
Clinical Lymphoma Myeloma and Leukemia
Accession number :
edsair.doi...........d95b6ff48bd5e728b6ed2a4f27b28ee5
Full Text :
https://doi.org/10.1016/s2152-2650(22)00602-4
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details